Therefore, long-term and persistent intervention with semaglutide is needed for the improvement of obesity
A beautiful, balanced plate does not help much if it feels impossible to eat
N Engl J Med 375:18341844 Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, hman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF (2017) EXSCEL Study Group
Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists Orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials
Mechanism Retatrutide is a triple agonist, targeting GIP, GLP-1, and glucagon receptors